Product
Cytokine-Induced Memory-like Natural Killer Cells
Aliases
CIML NK Cells
2 clinical trials
7 indications
Indication
Platinum-resistant Ovarian CancerIndication
Recurrent Ovarian CancerIndication
Ovarian CancerIndication
RecurrentIndication
Acute Myeloid LeukemiaIndication
LeukemiaIndication
myeloidClinical trial
A Phase 1b Study of Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cell Therapy in Combination With N-803 (Il-15 Superagonist) in Recurrent Ovarian CancerStatus: Not yet recruiting, Estimated PCD: 2026-11-30
Clinical trial
A Phase 1 Study of Cytokine-induced Memory-like (CIML) NK Cells With Venetoclax as Consolidation Therapy in AMLStatus: Active (not recruiting), Estimated PCD: 2026-11-30